Publication
Obinutuzumab in two patients suffering from immune-mediated thrombotic thrombocytopenic purpura intolerant to rituximab
Journal Paper/Review - Aug 9, 2019
Robertz Judith, Andres Martin, Mansouri Taleghani Behrouz, Koneth Irene, Binet Françoise-Isabelle, Kremer Hovinga Johanna A
Units
PubMed
Doi
Citation
Robertz J, Andres M, Mansouri Taleghani B, Koneth I, Binet F, Kremer Hovinga J. Obinutuzumab in two patients suffering from immune-mediated thrombotic thrombocytopenic purpura intolerant to rituximab. Am J Hematol 2019; 94:E259-E261.
Type
Journal Paper/Review (English)
Journal
Am J Hematol 2019; 94
Publication Date
Aug 9, 2019
Issn Electronic
1096-8652
Pages
E259-E261